Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 63554-63555 [2015-26569]
Download as PDF
63554
Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices
number for the Public Reading Room is
(202) 566–1744, and the telephone
number for the ORD Docket is (202)
566–1752.
Dated: October 15, 2015.
Fred S. Hauchman,
Director, Office of Science Policy.
The
Designated Federal Officer (DFO) via
´
mail at: Jace Cuje, Mail Code 8104R,
Office of Science Policy, Office of
Research and Development, U.S.
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460; via phone/voice mail at:
(202) 564–1795; or via email at:
cuje.jace@epa.gov.
BILLING CODE 6560–50–P
FOR FURTHER INFORMATION CONTACT:
The
Charter of the BOSC states that the
advisory committee shall provide advice
and recommendations on all aspects
(technical and management) of the
ORD’s research program. The BOSC is
federal advisory committee chartered
under the Federal Advisory Committee
Act (FACA), 5 U.S.C., App. 2.
Additional information about the BOSC
is available at: https://www2.epa.gov/
bosc.
This meeting is open to the public.
Any member of the public interested in
receiving a draft agenda, joining the
teleconference, or making a presentation
during the teleconference may contact
´
Jace Cuje, DFO, via any of the contact
methods listed in the FOR FURTHER
INFORMATION CONTACT section above.
Proposed agenda items for the meeting
include, but are not limited to, the
following: presentation and discussion
of the subcommittee’s draft responses to
the charge questions and approval of the
final draft letter report prior to its
submission to the BOSC Executive
Committee.
Written Statements: Written
comments for the public teleconference
must be received by noon Monday,
November 2, 2015, Eastern Time, so
they can be distributed to the BOSC
SHC Subcommittee prior to the
teleconference. Written comments
´
should be sent to Jace Cuje at the
address listed in the FOR FURTHER
INFORMATION CONTACT section or through
regulations.gov, Docket ID No. EPA–
HQ–ORD–2015–0611.
Information on Services for
Individuals with Disabilities: For
information on access or services for
individuals with disabilities, please
´
contact Jace Cuje at (202) 564–1795 or
cuje.jace@epa.gov. To request
accommodation of a disability, please
´
contact Jace Cuje, preferably at least ten
days prior to the meeting, to give the
EPA as much time as possible to process
your request.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:55 Oct 19, 2015
Jkt 238001
[FR Doc. 2015–26597 Filed 10–19–15; 8:45 am]
FEDERAL MEDIATION AND
CONCILIATION SERVICE
Labor-Management Relations
Information Collection Requests
Federal Mediation and
Conciliation Service.
ACTION: Submission for OMB Review:
Request for Comments.
AGENCY:
The Federal Mediation and
Conciliation Service (FMCS) hereby
announces the submission of the
following public information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(Pub. L. 104–13). The information
collection request is the Notice to
Mediation Agencies (Agency Form F–7),
OMB control number 3076–0004. No
comments were received pursuant to
FMCS’s prior 60-day notice in the
Federal Register on August 5, 2015.
This information collection request was
previously approved by OMB.
OMB is interested in comments on
specific aspects of the collection. The
OMB is particularly interested in
comments that:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluates the accuracy of the
agency’s estimates of the burden of the
proposed collection information;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collections of information on those who
are to respond, including the use of
appropriate automated, electronic
collection technologies or other forms of
information technology.
Burden: FMCS receives
approximately 14,400 responses to the
form Notice to Mediation Agencies
(OMB No. 3076–004).
Affected Entities: Private sector
employers and labor unions involved in
interstate commerce that file notices for
mediation services to the FMCS and
state, local and territorial agencies.
DATES: Comments must be submitted on
or before November 19, 2015.
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Submit written comments
to: Email: oira_submissions@
omb.eop.gov. Please include the FMCS
form number, the information collection
title, and the OMB control number in
the subject line of the message.
Comments may also be sent to fax
number 202.395.5806 to the attention of
Desk Officer for FMCS.
SUPPLEMENTARY INFORMATION: For
additional information, see the related
60-day notice published in the Federal
Register at 88 FR 46581 on August 5,
2015.
ADDRESSES:
Dated: October 14, 2015.
Jeannette Walters-Marquez,
Attorney Advisor.
[FR Doc. 2015–26513 Filed 10–19–15; 8:45 am]
BILLING CODE 6732–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3325–N]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS in making coverage
determinations under the Medicare
program.
The MEDCAC reviews and evaluates
medical literature and technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries.
SUMMARY:
Nominations must be received
by Monday, December 7, 2015.
ADDRESSES: You may mail nominations
for membership to the following
address: Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria
Ellis, 7500 Security Boulevard, Mail
DATES:
E:\FR\FM\20OCN1.SGM
20OCN1
Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Stop: S3–02–01, Baltimore, MD 21244
or send via email to
MEDCACnomination@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for the
MEDCAC, Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Coverage and
Analysis Group, S3–02–01, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410–786–0309) or via email at
Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The current
Secretary’s Charter for the MEDCAC is
available on the CMS Web site at: https://
www.cms.hhs.gov/FACA/Downloads/
medcaccharter.pdf, or you may obtain a
copy of the charter by submitting a
request to the contact listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
We are requesting nominations for
candidates to serve on the MEDCAC.
Nominees are selected based upon their
individual qualifications and not solely
as representatives of professional
associations or societies. We wish to
ensure adequate representation of the
interests of both women and men,
members of all ethnic groups, and
physically challenged individuals.
Therefore, we encourage nominations of
qualified candidates who can represent
these interests.
The MEDCAC consists of a pool of
100 appointed members including: 94
at-large standing members (6 of whom
are patient advocates), and 6
representatives of industry interests.
Members generally are recognized
VerDate Sep<11>2014
17:55 Oct 19, 2015
Jkt 238001
authorities in clinical medicine
including subspecialties, administrative
medicine, public health, biological and
physical sciences, epidemiology and
biostatistics, clinical trial design, health
care data management and analysis,
patient advocacy, health care
economics, medical ethics or other
relevant professions.
The MEDCAC works from an agenda
provided by the Designated Federal
Official. The MEDCAC reviews and
evaluates medical literature and
technology assessments, and hears
public testimony on the evidence
available to address the impact of
medical items and services on health
outcomes of Medicare beneficiaries. The
MEDCAC may also advise the Centers
for Medicare & Medicaid Services (CMS)
as part of Medicare’s ‘‘coverage with
evidence development’’ initiative.
II. Provisions of the Notice
As of June 2016, there will be 35
membership terms expiring. Of the 35
memberships expiring, 1 is an industry
representative, 4 are patient advocates,
and the remaining 30 membership
openings are for the at-large standing
MEDCAC membership.
All nominations must be
accompanied by curricula vitae.
Nomination packages should be sent to
Maria Ellis at the address listed in the
ADDRESSES section of this notice.
Nominees are selected based upon their
individual qualifications. Nominees for
membership must have expertise and
experience in one or more of the
following fields:
• Clinical medicine including
subspecialties
• Administrative medicine
• Public health
• Biological and physical sciences
• Epidemiology and biostatistics
• Clinical trial design
• Health care data management and
analysis
• Patient advocacy
• Health care economics
• Medical ethics
• Other relevant professions
We are looking particularly for
experts in a number of fields. These
include cancer screening, genetic
testing, clinical epidemiology,
psychopharmacology, screening and
diagnostic testing analysis, and vascular
surgery. We also need experts in
biostatistics in clinical settings,
dementia treatment, minority health,
observational research design, stroke
epidemiology, and women’s health.
The nomination letter must include a
statement that the nominee is willing to
serve as a member of the MEDCAC and
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
63555
appears to have no conflict of interest
that would preclude membership. We
are requesting that all curricula vitae
include the following:
• Date of birth
• Place of birth
• Social security number
• Title and current position
• Professional affiliation
• Home and business address
• Telephone and fax numbers
• Email address
• List of areas of expertise
In the nomination letter, we are
requesting that nominees specify
whether they are applying for a patient
advocate position, for an at-large
standing position, or as an industry
representative. Potential candidates will
be asked to provide detailed information
concerning such matters as financial
holdings, consultancies, and research
grants or contracts in order to permit
evaluation of possible sources of
financial conflict of interest. Department
policy prohibits multiple committee
memberships. A federal advisory
committee member may not serve on
more than one committee within an
agency at the same time.
Members are invited to serve for
overlapping 2-year terms. A member
may continue to serve after the
expiration of the member’s term until a
successor is named. Any interested
person may nominate one or more
qualified persons. Self-nominations are
also accepted. Individuals interested in
the representative positions must
include a letter of support from the
organization or interest group they
would represent.
Dated: October 13, 2015.
Patrick Conway,
CMS Chief Medical Officer and Director,
Center for Clinical Standards and Quality,
Centers for Medicare & Medicaid Services.
[FR Doc. 2015–26569 Filed 10–19–15; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Organization, Functions,
and Delegations of Authority
Administration for Children
and Families, HHS.
ACTION: Notice of reorganization.
AGENCY:
Statement of Organization,
Functions, and Delegations of
Authority. The Administration for
Children and Families (ACF) has
reorganized. The reorganization adds
SUMMARY:
E:\FR\FM\20OCN1.SGM
20OCN1
Agencies
[Federal Register Volume 80, Number 202 (Tuesday, October 20, 2015)]
[Notices]
[Pages 63554-63555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26569]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3325-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
membership on the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and
guidance to the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services (CMS) concerning the adequacy of
scientific evidence available to CMS in making coverage determinations
under the Medicare program.
The MEDCAC reviews and evaluates medical literature and technology
assessments, and hears public testimony on the evidence available to
address the impact of medical items and services on health outcomes of
Medicare beneficiaries.
DATES: Nominations must be received by Monday, December 7, 2015.
ADDRESSES: You may mail nominations for membership to the following
address: Centers for Medicare & Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard,
Mail
[[Page 63555]]
Stop: S3-02-01, Baltimore, MD 21244 or send via email to
MEDCACnomination@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
the MEDCAC, Centers for Medicare & Medicaid Services, Center for
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01,
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by
phone (410-786-0309) or via email at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial charter for the Medicare Coverage
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal
Register (63 FR 68780) announcing establishment of the MCAC was
published on December 14, 1998. The MCAC name was updated to more
accurately reflect the purpose of the committee and on January 26,
2007, the Secretary published a notice in the Federal Register (72 FR
3853), announcing that the Committee's name changed to the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC). The
current Secretary's Charter for the MEDCAC is available on the CMS Web
site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or
you may obtain a copy of the charter by submitting a request to the
contact listed in the FOR FURTHER INFORMATION CONTACT section of this
notice.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. App. 2), which
sets forth standards for the formulation and use of advisory
committees, and is authorized by section 222 of the Public Health
Service Act as amended (42 U.S.C. 217A).
We are requesting nominations for candidates to serve on the
MEDCAC. Nominees are selected based upon their individual
qualifications and not solely as representatives of professional
associations or societies. We wish to ensure adequate representation of
the interests of both women and men, members of all ethnic groups, and
physically challenged individuals. Therefore, we encourage nominations
of qualified candidates who can represent these interests.
The MEDCAC consists of a pool of 100 appointed members including:
94 at-large standing members (6 of whom are patient advocates), and 6
representatives of industry interests. Members generally are recognized
authorities in clinical medicine including subspecialties,
administrative medicine, public health, biological and physical
sciences, epidemiology and biostatistics, clinical trial design, health
care data management and analysis, patient advocacy, health care
economics, medical ethics or other relevant professions.
The MEDCAC works from an agenda provided by the Designated Federal
Official. The MEDCAC reviews and evaluates medical literature and
technology assessments, and hears public testimony on the evidence
available to address the impact of medical items and services on health
outcomes of Medicare beneficiaries. The MEDCAC may also advise the
Centers for Medicare & Medicaid Services (CMS) as part of Medicare's
``coverage with evidence development'' initiative.
II. Provisions of the Notice
As of June 2016, there will be 35 membership terms expiring. Of the
35 memberships expiring, 1 is an industry representative, 4 are patient
advocates, and the remaining 30 membership openings are for the at-
large standing MEDCAC membership.
All nominations must be accompanied by curricula vitae. Nomination
packages should be sent to Maria Ellis at the address listed in the
ADDRESSES section of this notice. Nominees are selected based upon
their individual qualifications. Nominees for membership must have
expertise and experience in one or more of the following fields:
Clinical medicine including subspecialties
Administrative medicine
Public health
Biological and physical sciences
Epidemiology and biostatistics
Clinical trial design
Health care data management and analysis
Patient advocacy
Health care economics
Medical ethics
Other relevant professions
We are looking particularly for experts in a number of fields.
These include cancer screening, genetic testing, clinical epidemiology,
psychopharmacology, screening and diagnostic testing analysis, and
vascular surgery. We also need experts in biostatistics in clinical
settings, dementia treatment, minority health, observational research
design, stroke epidemiology, and women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and appears to have no
conflict of interest that would preclude membership. We are requesting
that all curricula vitae include the following:
Date of birth
Place of birth
Social security number
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
Email address
List of areas of expertise
In the nomination letter, we are requesting that nominees specify
whether they are applying for a patient advocate position, for an at-
large standing position, or as an industry representative. Potential
candidates will be asked to provide detailed information concerning
such matters as financial holdings, consultancies, and research grants
or contracts in order to permit evaluation of possible sources of
financial conflict of interest. Department policy prohibits multiple
committee memberships. A federal advisory committee member may not
serve on more than one committee within an agency at the same time.
Members are invited to serve for overlapping 2-year terms. A member
may continue to serve after the expiration of the member's term until a
successor is named. Any interested person may nominate one or more
qualified persons. Self-nominations are also accepted. Individuals
interested in the representative positions must include a letter of
support from the organization or interest group they would represent.
Dated: October 13, 2015.
Patrick Conway,
CMS Chief Medical Officer and Director, Center for Clinical Standards
and Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2015-26569 Filed 10-19-15; 8:45 am]
BILLING CODE 4120-01-P